SILO PHARMA, INC. (SILO)
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
Compass Pathways - Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
lululemon Strengthens Presence in Mexico with E-Commerce Launch and Store Expansion Plan
Valens Semiconductor to Announce First Quarter 2026 Financial Results on May 13, 2026
Trane Technologies to Present at the Oppenheimer Industrial Growth Conference
All Three Independent Proxy Advisors Recommend Ingles Markets Shareholders Vote for Rory A. Held
PermRock Royalty Trust Declares Monthly Cash Distribution
Innovative Industrial Properties Announces First Quarter 2026 Earnings Release Date and Conference Call
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
U.S. GoldMining Mobilizes 2026 Exploration Program Targeting District-Scale Potential at the Whistler Project, Alaska